HR-8136-119
Referred to the House Committee on Financial Services.
Sponsored by Cleo Fields (D-LA)
What it does
This bill would direct the Comptroller General (head of the Government Accountability Office) to conduct and submit a study within one year examining how federal agencies currently procure and stockpile "long-lead items" — components that take a long time to design and manufacture — under the Defense Production Act of 1950. The study would identify ways agencies could better coordinate on procurement and stockpiling, and would provide legislative recommendations, including possible amendments to the Defense Production Act. The bill also makes a minor technical correction to the short title language of the Defense Production Act itself.
Who benefits
Federal agencies that rely on the Defense Production Act and could gain clearer guidance on procurement practices. Defense and critical-infrastructure industries that supply long-lead components, who may benefit from more predictable government purchasing. Congress, which would receive actionable recommendations for potential legislative changes. Taxpayers broadly, if improved procurement practices reduce waste or supply chain failures. Communities dependent on domestic manufacturing of critical components, who could benefit from more stable demand signals.
Who is hurt
Foreign suppliers of long-lead components, who could face reduced market access if recommendations lead to more domestic-sourcing requirements. Federal agencies that may face administrative burden in cooperating with the GAO study. Competing legislative priorities may be crowded out if the study's recommendations lead to significant DPA amendments. There are no direct financial costs imposed on private parties by this bill itself.
Supporters argue
Supporters argue that supply chain vulnerabilities exposed during recent crises — including shortages of semiconductors, pharmaceuticals, and industrial components — demonstrate that the federal government lacks a coherent strategy for procuring and stockpiling long-lead items before emergencies arise. They contend that a GAO study is a low-cost, evidence-based first step toward closing those gaps, and that legislative recommendations from an independent, nonpartisan body like the GAO are more likely to produce durable, effective policy changes than ad hoc agency action.
Opponents argue
Opponents argue that the federal government has already commissioned numerous studies on supply chain resilience and Defense Production Act effectiveness, and that another GAO report risks duplicating existing work without producing meaningful change. They contend that the bill's one-year timeline and broad scope may result in recommendations too general to drive concrete action, and that Congress would be better served by directly legislating specific procurement reforms rather than deferring to a study that carries no binding authority.
Constitutional context
No significant constitutional issues are raised by this bill. Directing the GAO — a legislative branch agency — to conduct a study and report to Congress is a routine exercise of Congress's oversight and investigative functions, well within its implied powers under Article I. No Commerce Clause, delegation, or takings issues are implicated by a study mandate alone.
Checks and balances
Congress gains informational leverage over the executive branch by directing the GAO (a legislative branch entity) to evaluate executive agency procurement practices; the study carries no binding authority over agencies, and any resulting legislative changes would require the full legislative process.
Historical precedent
The GAO has previously conducted studies on Defense Production Act implementation and supply chain readiness, including reviews following COVID-19-era shortages of medical supplies and personal protective equipment.